Cetuximab for esophageal cancer: an updated meta-analysis of randomized controlled trials

BACKGROUND: Increasing evidence indicates that cetuximab (CET) combined with chemoradiotherapy may be effective for patients with esophageal cancer. However, the recent results are still contradictory and no consensus has yet been reached on this issue. To evaluate the clinical effects and safety of...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:BMC Cancer
Main Authors: Huang, Ze-Hao, Ma, Xiao-Wen, Zhang, Jing, Li, Xiao, Lai, Na-Lin, Zhang, Sheng-Xiao
Format: Artigo
Jezik:Inglês
Izdano: BioMed Central 2018
Teme:
Research Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC6258395/
https://ncbi.nlm.nih.gov/pubmed/30477458
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-018-5040-z
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki